Articles tagged with Parkinsons Disease
A widely used dry cleaning chemical, trichloroethylene (TCE), may be fueling the rise of Parkinson's disease. Exposure to TCE has been linked to an increased risk of developing the condition, particularly among individuals who worked with or lived near contaminated sites.
Researchers used AI to analyze literature describing compounds that enhance mitophagy, a process damaged in Parkinson's disease. Probucol, a cholesterol-lowering drug, was identified as the most effective compound with improved motor function and neuron loss in animal models.
A tiny worm called C. elegans is enabling scientists to explore the emerging theory that Parkinson’s disease starts in the gut, where a sticky protein causes neurons to die. The worms have a digestive tract and neurotransmitters similar to humans, making them a great model for studying cognitive problems associated with Parkinson's.
A patient with Parkinson's disease has received a pioneering stem cell-based transplant at Skåne University Hospital in Sweden. The procedure aims to replace lost dopamine nerve cells and is part of a clinical trial testing the safety and efficacy of this innovative treatment, which could potentially help millions of people worldwide.
A study by Nagoya University researchers identified three intestinal bacteria - Collinsella, Ruminococcus, and Bifidobacterium - linked to dementia with Lewy bodies. These findings may help diagnose and treat the neurodegenerative disease, with potential therapeutic interventions targeting specific bacteria.
A team of biologists and engineers created a miniature facility called the Acoustic Gym to study exercise in tiny worms. They found that swimming exercises reduced neurodegeneration in genetically engineered worms with Parkinson's-like symptoms, which could lead to new treatments for humans.
Researchers identified a gene linked to Parkinson's Disease also contributes to cell debris buildup in the brain. Autophagy disruption leads to toxic waste accumulation and neuron death, hallmarks of the disease. The discovery could pave the way for new, more effective treatments by targeting autophagy.
A research group at Uppsala University has developed an artificial blood-brain barrier model that can validate the effectiveness of antibodies in reaching the brain. The model allows for the testing of antibodies without the need for animal experimentation, providing a more efficient and cost-effective alternative.
A preliminary study found a nationwide association between Parkinson's disease and air pollution exposure, with the highest levels of fine particulate matter linked to increased risk. The Mississippi-Ohio River Valley was identified as a hotspot for Parkinson's disease, where risk increases with increasing air pollution exposure.
A new study led by University of Maryland School of Medicine researchers found that focused ultrasound treatment significantly reduced tremors and improved mobility in Parkinson's patients. Nearly 70% of treated patients showed a successful response after three months, with two-thirds continuing to respond a year later.
A study published in PNAS reveals how environmental signals interact with genetic information to influence brain cell health and survival. The research highlights a protein called TNK2 that tunes dopamine levels, finding mutations lead to Parkinson's degeneration.
Researchers have discovered a method to detect α-synuclein aggregates in stool samples, indicating an early form of Parkinson's disease. This finding could lead to the development of a non-invasive diagnostic tool, enabling therapies to be initiated at an early stage.
Researchers create advanced imaging-based method for studying mitochondria, enabling detailed mapping and measurement of structural changes. This technique has potential applications in understanding diseases such as Alzheimer’s, Parkinson’s, and cancers where mitochondrial function is disrupted.
NeuralTree is a closed-loop neuromodulation system-on-chip that can detect and classify biomarkers from real patient data and animal models of disease in-vivo, leading to high accuracy in symptom prediction. The system boasts 256 input channels, making it highly versatile and scalable.
A new electrochemical sensor has been developed to detect dopamine levels in biological fluids, potentially leading to earlier disease detection for conditions like Parkinson's disease and depression. The method uses carbon quantum dots and ionic liquids, offering a quick and sensitive test.
Lithuanian researchers have developed an AI system to detect early symptoms of Parkinson's disease using voice data. The study found that patients with early-stage Parkinson's often speak in a quieter, more monotonous tone, which can be difficult to notice by ear.
Researchers at UCLA have created the first synthetic version of lissodendoric acid A, a sea sponge-derived molecule with potential therapeutic benefits for Parkinson’s disease and similar disorders. The team developed a method that employs cyclic allenes to produce only the desired enantiomer of the molecule.
Swansea University scientists developed a smart patch that can detect proinflammatory biomarkers of neurodegenerative diseases, including Alzheimer's, using microneedle technology. The patches can be self-administered for point-of-care diagnosis and have the potential to change the landscape of early disease detection.
A new nanopore-based sensing device explores the aggregation of tau and tubulin proteins in neurodegenerative diseases such as Alzheimer's and Parkinson's. The device provides volume information about protein molecules and their states at the single-molecule level, offering insights into protein binding and aggregation.
A recent study published in Nature Communications has found a significant imbalance in the gut microbiome of individuals with Parkinson's disease. The researchers discovered that over 30% of micro-organisms and bacterial genes tested had altered abundances, indicating a widespread imbalance in the microbiome.
A new algorithm developed by researchers at Charité improves motor symptoms comparable to standard of care treatment, increasing efficiency in deep brain stimulation for Parkinson's disease. The study suggests a promising result for imaging-based algorithms to simplify clinical practice and improve therapeutic outcomes.
A recent study has identified common and unique cellular processes in six neurodegenerative diseases, providing new insights into the underlying causes of these conditions. The research used machine learning analysis to compare RNA markers in whole blood samples from patients with distinct diseases, revealing eight shared themes across...
A new study found the annual incidence of Parkinson’s disease in the U.S. to be nearly 90,000 cases per year, a 50% increase from previous estimates of 60,000 diagnoses annually. The increased incidence is attributed to an aging population and highlights the need for more research and better treatments.
A recent study suggests that stimulating the intersection of two particular brain networks correlated with better patient outcomes than stimulating nearby sites for patients with Alzheimer's disease. Cognitive improvement was associated with DBS to the direct interface between the fornix and bed nucleus of the stria terminalis.
Researchers from IIT have discovered a correlation between small RNA molecules, piRNAs, and brain inflammation. The study lays the groundwork for new diagnostic technologies to detect neurodegenerative diseases, such as Alzheimer's and Parkinson's, at an early stage.
A study published in the Hypertension journal suggests that bromocriptine, a Parkinson's disease medication, may help prevent heart disease in youth with Type 1 diabetes. The research found that teens with Type 1 diabetes who took bromocriptine had lower blood pressure and less stiff arteries after one month of treatment.
A new laboratory test can measure levels of amyloid beta oligomers in blood samples, detecting toxic proteins up to years before cognitive impairment. The test, SOBA, has shown promising results in identifying individuals at risk or incubating Alzheimer's disease.
Researchers investigated neuronal response to excessive iron accumulation associated with age-related neurodegenerative diseases. They identified two genes, CLU and HERPUD1, that responded to aging-related iron accumulation, highlighting potential preventative strategies.
The latest research evidence suggests that inflammation may play a causative role in Parkinson's disease. Multiple independent studies have provided evidence of the involvement of central and peripheral immune and inflammatory processes in PD, with increasing evidence suggesting an association with autoimmune conditions.
Researchers have discovered that a specific mutation in the misfolding protein causing Parkinson's disease can also protect against multiple system atrophy (MSA), another fatal neurodegenerative disorder. The findings provide a promising lead for developing targeted treatments using personalized medicine approaches.
A recent study published in Nature Computational Science reveals that specific regions of the brain process both individual and combined words, while others focus solely on individual words. The research could contribute to the development of wearable neurotechnology devices that can decode language directly from brain activity.
Researchers at ETH Zurich have identified 76 proteins that could serve as biomarkers for Parkinson's disease, with their molecular structures differing between healthy and diseased individuals. The study uses a unique method to analyze protein shapes in cerebrospinal fluid, providing a promising new approach for diagnosis and potential...
Researchers discovered that krill oil protects dopaminergic neurons from age-related degeneration through temporal transcriptome rewiring and suppression of several hallmarks of aging. Krill oil increases neuronal resilience, promoting anti-oxidative stress and anti-inflammation, and abrogating multiple aging hallmarks.
Researchers developed an AI model to analyze spatial and temporal gait parameters, identifying key features for diagnosing Parkinson's. The model achieved high diagnostic accuracy, reducing the probability of error in clinical assessments.
Researchers at University of Cambridge found that a thin shell of water surrounding proteins can determine aggregation, with slower movement leading to more clumping. The discovery has significant implications for treating protein misfolding diseases like Parkinson's and Alzheimer's.
A five-year review of focused ultrasound treatment for essential tremor found that patients experienced significant reductions in tremor symptoms, with benefits lasting long-term and no reported progressive or delayed complications. The study represents the largest long-term assessment yet conducted on the procedure.
Scientists at WashU Medicine have discovered that immune cells surrounding the brain play a crucial role in clearing toxic clusters of proteins. Treating old mice with an immune-stimulating compound rejuvenates these cells, improving waste clearance and holding promise for treating neurodegenerative diseases like Alzheimer's.
Researchers at OHSU discovered adenosine effectively acts as a brake to dopamine, promoting balance in neuronal signaling. This finding suggests new avenues for drug development to treat Parkinson's disease symptoms by targeting the push-pull dynamic between dopamine and adenosine.
The study highlights the importance of the gut microbiome in metabolic conditions like obesity and neurological diseases such as Parkinson's. Pesticide exposure is also found to disrupt the gut microbiota, leading to brain-gut alterations that can exacerbate these conditions.
A team of researchers has deciphered the molecular mechanism linked to juvenile Parkinson's disease, a genetic mutation affecting the adenosine type 1 receptor gene. The mutation alters the interaction between adenosine receptors, leading to increased neuronal circuit excitability in the brain region striatum.
A University of Colorado study reveals aggressive behavior towards caregivers is a significant issue in Parkinson's disease, with factors including grief, loss of motor symptoms, and cognitive fluctuations identified as contributing to the problem. The research also highlights the impact on caregivers' mental health and relationships.
A randomized controlled trial found that oral ENT-01 significantly improves constipation and possibly neurological symptoms in persons with Parkinson disease. The treatment is safe for up to 25 days, with a dose-dependent effect that persists beyond the treatment period.
Researchers have developed a new gene therapy that selectively targets overactive brain cells, reducing excitability and suppressing seizures in mice. The treatment shows promise for treating neurological disorders such as epilepsy, Parkinson's disease, schizophrenia, and pain disorders.
Research suggests exercise-induced activation of peripheral systems, such as muscle, gut, and liver, may affect neural plasticity and cognitive health. Circulating cathepsin B (CTSB) and brain-derived neurotrophic factor (BNDF) have been found to possess robust neuroprotective effects.
Researchers have discovered that mutations in mitochondrial-related genes can trigger hyperinflammation, leading to diseases such as Crohn's disease and tuberculosis. The study found that these mutations lead to a new type of cell death called necroptosis, which causes an aggressive inflammatory immune response.
A new computational model based on fruit fly brain data may help explain how humans process memories and experiences. The model suggests that living organisms, including humans, use a similar '1-2-3-many' count sketch to track encounters with familiar sights and smells.
Researchers will investigate immune system differences between men and women to better understand neurodegenerative diseases. The study aims to identify why certain neurological diseases primarily affect males or females, and how this difference impacts disease progression.
Researchers identified a compound that reverses damage to brain cells caused by Parkinson's disease and breaks a self-sustaining molecular loop between LRRK2 and AICD. The potential drug itanapraced has passed safety tests and could improve quality of life for those afflicted with PD and Alzheimer's disease.
A study published in Neurology found that people with Parkinson's disease who gained weight had slower declines in thinking skills compared to those who lost weight. Weight management may play a crucial role in slowing cognitive decline in early Parkinson's.
Researchers discovered more than 200 genes with different epigenetic marks in Parkinson's disease brain neurons, but the affected genes were almost entirely different in men and women. The study opens up new avenues for investigation into how these genes contribute to the disease.
Researchers identified a kinase molecule that directs microglia activity, potentially treating neurodegenerative diseases like Alzheimer's and MS. The molecule, called spleen tyrosine kinase, targets plaque buildup and debris accumulation in the brain.
Researchers have discovered that zinc ions tune the ability of human serum albumin to prevent α-synuclein aggregation, a process linked to Parkinson's disease. Zinc binding alters HSA's chaperone function, blunting fibril formation and slowing down protein deposition that can lead to neurodegeneration.
Researchers have identified cognitive impairment in patients with dementia-related diseases up to 9 years before diagnosis, raising hope for earlier interventions and clinical trial recruitment. The study analyzed UK Biobank data and found subtle impairments in problem-solving and memory across various conditions.
A team of researchers used digital cameras and machine learning algorithms to develop a system that can predict gait dysfunctions in people with multiple sclerosis and Parkinson's disease. The study revealed that several algorithms were over 75% accurate at detecting differences between those with the conditions and those without.
A new screening test App can produce accurate results using just people's voice recordings, improving the management of Parkinson's disease and severe COVID-19. The smartphone App takes just 10 seconds to reveal whether a person may have Parkinson’s disease and should be referred to a neurologist.
Researchers from the University of Cincinnati found that low levels of soluble amyloid-beta protein in the brain, rather than its buildup into plaques, are associated with cognitive decline and Alzheimer's disease. Patients with high levels of soluble amyloid-beta showed improved cognitive outcomes, contradicting previous theories.
Researchers developed a machine learning model to quickly recognize predictive risk factors and their importance for undesirable hospitalization outcomes. The model achieved an accuracy of 95.6% and identified modifiable risk factors that can be mitigated through clinical interventions.
The National Institutes of Health has awarded a $10.7 million grant to Cleveland Clinic to expand a national research consortium focused on improving diagnosis and treatments for Dementia with Lewy Bodies. The consortium, which includes multiple clinical sites, aims to identify biomarkers for disease and develop new therapies.
Researchers from Xi'an Jiaotong-Liverpool University found that brain stimulation combined with a nose spray containing nanoparticles can improve recovery after ischemic stroke. The treatment increased cognitive and motor functions, and weighed more quickly than those treated with TMS alone.
Researchers have successfully created dopaminergic neurons directly from the skin of patients with Parkinson's disease, preserving aged characteristics and cellular defects. This breakthrough allows for modeling PD-related neuronal defects in a larger cohort of patients, aiming to identify disease causes and potential therapies.